Zero-order release profile of metoclopramide hydrochloride sublingual tablet formulation

References

• Joshi HN, Tejwani RW, Davidovich M, Sahasrabudhe VP, Jemal M, Bathala MS et al. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int J Pharm 2004;269:251–258.
   PubMed Web of Science ®Google Scholar
• Vogt M, Vertzoni M, Kunath K, Reppas C, Dressman JB. Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs. Eur J Pharm Biopharm 2008;68:338–345.
   PubMed Web of Science ®Google Scholar
• Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery - a review. Pharm Sci Technol Today 2000;3:138–145.
   PubMedGoogle Scholar
• Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev 2005;57:247–265.
   PubMed Web of Science ®Google Scholar
• Sakr FM. A programmable drug delivery system for oral administration. Int J of Pharm 1999; 184:131–139.
   PubMed Web of Science ®Google Scholar
• Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med 1997;15:357–365.
   PubMedGoogle Scholar
• Lin JH, Chiba M, Baillie TA. Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol Rev 1999;51:135–158.
   PubMed Web of Science ®Google Scholar
• Kulkarni B, Wu K, Basu S, Zhang S, Hu M. First-Pass metabolism via UDP-Glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci 2011;100:3655–3681.
   PubMed Web of Science ®Google Scholar
• Rathbone MJ, Drummond BK, Tucker JG. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 1994; 13: 1–22.
   Web of Science ®Google Scholar
• Artusi M, Santi P, Colombo P, Junginger HE. Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. Int J Pharm 2003;250:203–213.
   PubMed Web of Science ®Google Scholar
• McElnay JC, Hughes CM. Drug delivery: buccal route. Encycl of Pharm Technol 2006;1:1071–1081.
   Google Scholar
• Bredenberg S, Duberg M, Lennernäs B, Lennernäs H, Pettersson A, Westerberg M et al. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. Eur J Pharm Sci 2003;20:327–334.
   PubMed Web of Science ®Google Scholar
• Hoogstraate JAJ, Wertz PW. Drug delivery via the buccal mucosa. PSTT1998;1:309–316.
   Google Scholar
• McInnes F, Clear N, James G, Stevens HN, Vivanco U, Humphrey M. Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy. Pharm Res 2008;25:869–874.
   PubMed Web of Science ®Google Scholar
• Al-Ghananeem AM, Malkawi AH, Crooks PA. Effect of pH on sublingual absorption of oxycodone hydrochloride. AAPS PharmSciTech 2006;7:E23.
   Web of Science ®Google Scholar
• Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery–a promising option for orally less efficient drugs. J Control Release 2006;114:15–40.
   PubMed Web of Science ®Google Scholar
• Junginger HE, Hoogstraate JA, Verhoef JC. Recent advances in buccal drug delivery and absorption–in vitro and in vivo studies. J Control Release 1999;62:149–159.
   PubMed Web of Science ®Google Scholar
• Ayensu I, Mitchell JC, Boateng JS. Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa. Colloids Surf B Biointerfaces 2012;91:258–265.
   PubMed Web of Science ®Google Scholar
• Mizumotoa T, Masudaa Y, Yamamotob T, Yonemochi E, Terada K. Formulation design of a novel fast-disintegrating tablet. Int J of Pharm 2005;306:83–90.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Sugaya M, Nakano Y, Izutsu D, Mizukami Y, Okochi K et al. Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets. Chem Pharm Bull 2003;51:1121–1127.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Mukai B, Shiraishi S, Utoguchi N, Fujii M, Matsumoto M et al. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropyl cellulose or spherical sugar granules by direct compression method. Chem Pharm Bull 2001;49:134–139.
   PubMed Web of Science ®Google Scholar
• Kuno Y, Kojima M, Ando S, Nakagami H. Effect of preparation method on properties of orally disintegrating tablets made by phase transition. Int J Pharm 2008;355:87–92.
   PubMed Web of Science ®Google Scholar
• Drug.com.2000–2012, Drug Information. [on line]. Available at: http://www.drugs.com/metoclopramide.html. Accessed on: 15 February 2012.
   Google Scholar
• Jonnalagadda S, Robinson DH. A bioresorbable, polylactide reservoir for diffusional and osmotically controlled drug delivery. AAPS PharmSciTech 2000;1:E29.
   Google Scholar
• Bravo SA, Lamas MC, Salamón CJ. In vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices. J Pharm Pharm Sci 2002;5:213–219.
   PubMed Web of Science ®Google Scholar
• Syed IA, Narsub ML, Raoc YM. In vitro release kinetics and bioavailability of oral controlled release layered matrix tablets of diltiazem hydrochloride. Int. J Drug Dev & Res 2011; Jan-March 3:234–241.
   Google Scholar
• USP/NF. Physical Tests: Tablet friability (1216). 26/21 ed. Rockville, MD: United States Pharmacopeial Convention Inc, 2003.
   Google Scholar
• USP/NF. Physical Tests: Uniformity of dosage units (905). 26/21 ed. Rockville, MD: United States Pharmacopeial Convention Inc, 2003.
   Google Scholar
• Rawas-Qalaji MM, Simons FE, Simons KJ. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics. AAPS PharmSciTech 2006;7:E41.
   PubMed Web of Science ®Google Scholar
• Rawas-Qalaji MM, Simons FE, Simons KJ. Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics. Drug Dev Ind Pharm 2007;33:523–530.
   PubMed Web of Science ®Google Scholar
• Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci 2002;15:295–305.
   PubMed Web of Science ®Google Scholar
• Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 2002;122:188–198.
   Google Scholar
• Fukami J, Yonemochi E, Yoshihashi Y, Terada K. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm 2006;310:101–109.
   PubMed Web of Science ®Google Scholar
• Patil MG, Kakade SM, Pathade SG. Formulation and evaluation of orally disintegrating tablet containing tramadol hydrochloride by mass extrusion technique. J of Appl Pharm Sci 2011;1:178–181.
   Google Scholar
• Jug M, Becirevic-Lacan M. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci 2004;21:251–260.
   PubMed Web of Science ®Google Scholar
• Azarmi S, Roa W, Löbenberg R. Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharm 2007;328:12–21.
   PubMed Web of Science ®Google Scholar
• Aburahma MH, El-Laithy HM, Hamza Yel-S. Preparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxy Acid. Sci Pharm 2010;78:363–379.
   PubMedGoogle Scholar
• Wikipedia, the free encyclopedia, 2012, Mannitol [online]. Available at: http: www. en.wikipedia.org/wiki/Mannitol. Accessed on: 7 March 2012.
   Google Scholar
• FMC BioPolymer, 2012, Ac-Di-Sol [online]. Available at: http:www.fmcbiopolymer.com/Pharmaceutical/Products/.../AcDiSol.aspx>. Accessed on: 7 March 2012.
   Google Scholar
• Landgraf W, Li N-H, Benson J. Polymer microcarrier exhibiting zero-order release. Drug Deliv Technol 2003;3:56–63.
   Google Scholar
• Landgraf W., Li N-H, Benson J. New polymer enables near zero-order release of drugs. Drug Deliv Technol 2005;5:48–55.
   Google Scholar